- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 14th, 2008
When the idea for a new drug-delivery company called BIND Biosciences Inc. started percolating in a lab here four years ago, venture capitalists quickly offered to invest.
One moneyman, though, had an inside track: Terry McGuire, a partner with nearby Polaris Venture Partners. Mr. McGuire was familiar with BIND's nanoparticle technology to treat tumors and heart disease. He's also a friend, and frequent business partner, of Robert Langer, the decorated scientist who runs the Massachusetts Institute of Technology lab. That relationship often gives Polaris first dibs on cutting-edge medical technology developed there.
|Related News Press|
News and information
Kalam: versatility personified August 1st, 2015
Gold-diamond nanodevice for hyperlocalised cancer therapy: Gold nanorods can be used as remote controlled nanoheaters delivering the right amount of thermal treatment to cancer cells, thanks to diamond nanocrystals used as temperature sensors August 1st, 2015
Take a trip through the brain July 30th, 2015
Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015
Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015